AKR1C2 and hyperandrogenism: We conclude that subcutaneous adipocytes are a site of 5α-DHT inactivation through AKR1C2, and that inhibitors of AKR1C2 could contribute to hyperandrogenism and elevate 5α-DHT levels in an intracrine-dependent manner.